Furthermore, it can downregulate the expression of SREBP-1, acetyl-CoA carboxylase (ACC), ATP- citrate lyase (ACLY), and FAS, decrease the levels of TC and TG, and ameliorate liver steatosis [134]. This evidence concerns the gene ACLY and fatty liver disease.